Drugs known to worsen asthma symptoms may indeed be beneficialApril 10th, 2008 - 1:26 pm ICT by admin
Washington, Apr 10 (ANI): A scientist from the University of Huston (UH) has shown that drugs known to worsen asthma symptoms can actually help patients breathe easier in the long run.
Richard Bond, associate professor of pharmacology at UH, based his study on the hypothesis that treating patients with medicine that initially worsens their symptoms before, can eventually improve their overall health and used beta-blockers (or antagonists) instead of stimulants (or agonists) in asthmatics.
He first conducted his studies on mice and later moved on to two clinical trials with humans.
Acute use of beta blockers by asthmatics has long been thought to be contraindicated, as it may cause increased airway resistance. While the use of beta-stimulants is known to provide temporary relief, their effectiveness declines over time.
The trials conducted over humans revealed that while beta-blockers initially made breathing problems worse, their continued use resulted in improved respiratory function after a 28-day period.
Acute use of beta-blockers alleviated asthma by helping the smooth muscle lining the airways to relax and dilate, thereby allowing air to flow more freely.
During study conducted over mice and humans, mild asthmatics were treated for nine weeks with the beta blocker nadolol, with all subjects tolerating the drug and 80 percent experiencing a reduction in airway hyperresponsiveness. The results were similar in both humans and mouse models.
The principle that certain pharmacological compounds have different effects depending upon whether they are given for long or short periods has been demonstrated, Bond said.
And even if I am correct about beta blockers ultimately being used in the treatment of asthma, there probably always will be a need for the inhaler-type agonist drugs to handle acute asthma attacks.
I do believe, though, that beta blockers hold promise in a maintenance or preventative regimen that could reduce the number or severity of attacks and improve a patients quality of life, he added.
The study conducted over mice was recently published in the American Journal of Respiratory Cell and Molecular Biology while the results of the first human trial were recently published in Pulmonary Pharmacology and Therapeutics. (ANI)
- Now, alternate therapy for adults with poorly controlled asthma - Sep 20, 2010
- Beta-blockers 'linked to benefits in patients with lung disease' - May 25, 2010
- Beta-blockers-anti-hypertensive drugs combo lowers high BP - Jan 20, 2010
- Delayed symptoms ravage asthmatics - Aug 14, 2011
- Study opposes current drug treatment for asthma management - Jan 27, 2009
- Social stress accelerates development of atherosclerosis - Dec 07, 2010
- Asthma linked to bacterial communities in the airway - Feb 18, 2011
- Beta-blockers for heart patients a double-edged sword - Nov 22, 2009
- Estrogen may reduce airway constriction in asthmatic women - May 17, 2010
- Drugs may halt stress signals from travelling to the heart - Sep 07, 2009
- Heart drug could make you less racist! - Mar 08, 2012
- Four novel biomarkers that may help diagnose asthma, COPD identified - Mar 12, 2011
- Tool to detect contaminants in cow, goat, human milk - Jul 06, 2011
- Scientists eliminate plaque formation in Alzheimer's - Sep 06, 2012
- Asthmic kids on steroids grow slightly shorter - Sep 04, 2012
Tags: acute asthma attacks, agonists, airway hyperresponsiveness, airway resistance, antagonists, asthma symptoms, asthmatics, beta blocker, beta blockers, mouse models, nadolol, nine weeks, pharmacological compounds, respiratory function, richard bond, short periods, smooth muscle, temporary relief, treatment of asthma, university of huston